Intrahospital supervised exercise training improves survival rate among hypertensive patients with COVID-19

Francisco Fernandez1,2, Manuel Vazquez-Muñoz3,4, Andrea Canals5

  • 1Exercise Applied Physiology Laboratory, Centro de Investigación en Fisiología y Medicina de Altura, Departamento Biomedico, Facultad de Ciencias de la Salud, Universidad de Antofagasta, Antofagasta, Chile.

Insights

Supervised exercise training (EX) significantly improved survival rates in hospitalized patients with hypertension (HTN) and COVID-19. This intrahospital program offers a feasible approach to enhance outcomes for this vulnerable patient group.

Area of Science:

  • Cardiology
  • Pulmonology
  • Sports Medicine
  • Infectious Diseases

Background:

  • Hypertension (HTN) is a major risk factor for severe coronavirus disease 2019 (COVID-19).
  • Standard pharmacological treatments for HTN do not effectively mitigate COVID-19 progression or severity.
  • Exercise training (EX) is proposed as a potential post-COVID treatment, with possible benefits during hospitalization.

Purpose of the Study:

  • To evaluate the impact of supervised exercise training (EX) on hospitalized patients diagnosed with both hypertension (HTN) and COVID-19.
  • To determine if EX during hospitalization improves survival rates in this specific patient cohort.

Main Methods:

  • A total of 439 hospitalized COVID-19 patients with HTN were divided into an EX group (n=201) and a control group (n=238).
  • The EX group underwent supervised aerobic, breathing, and musculoskeletal exercises 3-4 times per week throughout their hospitalization.
  • Aerobic exercises included walking (15-45 min), breathing exercises focused on diaphragmatic and pursed-lip techniques (10-15 min), and resistance training (8-10 sets/wk).

Main Results:

  • The supervised EX intervention demonstrated a significant improvement in survival rates among hypertensive COVID-19 patients compared to the control group (P=0.027).
  • Multivariate logistic regression identified EX as a significant prognostic marker for survival (OR=0.449, P=0.018), alongside sex and ventilation status.
  • The intrahospital EX program was associated with a reduced mortality rate in hypertensive patients hospitalized with COVID-19.

Conclusions:

  • Supervised intrahospital exercise training is an effective strategy for improving survival rates in hypertensive patients with COVID-19.
  • EX represents a feasible and therapeutically beneficial approach to enhance clinical outcomes for COVID-19 patients suffering from hypertension during hospitalization.
  • These findings support the integration of exercise interventions into the care of hospitalized hypertensive COVID-19 patients.

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
931
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
1.2K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
22
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
298
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
21